S2 Ep47: Crowdfunding and the High Cost of Cancer
CURE Talks Cancer18 Syys 2019

S2 Ep47: Crowdfunding and the High Cost of Cancer

In this week’s episode of the “Cure Talks Cancer” podcast, we spoke with Benjamin Breyer, M.D., about a phenomenon that’s raising big questions, big concerns and big money across the cancer landscape: crowdfunding.

As cancer progresses and financial alternatives grow fewer, many diagnosed patients in the US are turning to online crowdfunding to soften the financial blow and make ends meet. A recent study published in the Journal of the American Medical Association’s Internal Medicine issue paints a stark portrait: since the popular crowdfunding platform GoFundMe.com launched in May of 2010, patients, advocates and caregivers have piloted more than 37,000 fundraising campaigns specifically geared toward overcoming cancer’s monetary challenges. For Breyer, an associate professor at the University of California, San Francisco’s Department of Epidemiology and Biostatistics and the lead author of the study, mapping and understanding the crowdfunding phenomenon is an important step in the journey toward increasing advocacy for reduced healthcare costs. “I became really interested in hearing some of these people’s stories,” Breyer said in an interview with CURE. “The more we read their narratives and understood what they were going through, it really stood out to us that for a lot of people, getting care for cancer can be financially devastating.”

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(297)

S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma

S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb to launch "Investigating Myeloma," a disease awareness campaign honoring the 20th anniversary of her father Mickey Hargitay'...

8 Syys 6min

S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter

S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter

In our season 8 premiere, actor and longtime breast cancer advocate Rob Lowe joins CURE Talks Cancer to share his grandmother's breast cancer journey, including the clinical trial that helped prolong ...

31 Elo 14min

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
utelias-mieli
rss-duodecim-lehti
rss-hereilla
docemilia
rss-radplus
rss-kasvikutsut
rss-normaalivinouma
rss-vaasan-yliopiston-podcastit
rss-poliisin-mieli